Guest Editorial Federal funding cutbacks undermine advances in cancer research and treatmentWhat would Richard Nixon and Ted Kennedy think? June 20, 2025Vol.51 No.24By Donald L. "Skip" Trump and Eric T. Rosenthal
Guest Editorial An opportunity for Trump: Position U.S. cancer science to lead the world May 16, 2025Vol.51 No.19By Wafik S. El-Deiry
FreeGuest Editorial First exhibit at Museum of Medicine and Biomedical Discovery to focus on the history of cancer researchFrom despair to discovery to triumph May 16, 2025Vol.51 No.19By Mace L. Rothenberg
Guest Editorial George Weiner: Cancer centers are special, as are site visits in CCSG review May 09, 2025Vol.51 No.18By George J. Weiner
Guest Editorial In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same April 25, 2025Vol.51 No.16By W. Kimryn Rathmell
Guest Editorial Regulation must keep up with scientific advances April 25, 2025Vol.51 No.16By Richard M. Goldberg
Guest Editorial What would Mary do?Trump’s actions call for Lasker-style advocacy April 18, 2025Vol.51 No.15By Kevin J. Cullen
Guest Editorial Rathmell: We must put the individual at the center of our approach to ending cancer April 04, 2025Vol.51 No.13By W. Kimryn Rathmell
Guest Editorial Rathmell: We must support our junior colleagues“Empathy and listening is a key place to start” March 28, 2025Vol.51 No.12By W. Kimryn Rathmell
Guest Editorial Weill Cancer Hub East to investigate connections between metabolism and anti-tumor immunityWeill Cornell, Rockefeller, Princeton and the Ludwig Institute for Cancer Research showcase the power of collaboration March 28, 2025Vol.51 No.12By Jedd D. Wolchok, Joshua D. Rabinowitz and Sohail Tavazoie
